The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
UK MHRA approves Sobi’s efanesoctocog alfa to prevent and treat bleeding in children and adults with severe or moderate haemophilia A: United Kingdom Monday, February 17, 2025, ...
This national approval was granted after an Access Consortium new active substance work-sharing initiative (NASWSI) procedure. The Medicines and ...
The MHRA has issued guidance to help manufacturers ensure that digital mental health technologies are effective, reliable and ...
UK MHRA grants marketing authorization to Telix’s prostate cancer PET imaging agent, Illuccix: Melbourne, Australia Friday, February 14, 2025, 10:00 Hrs [IST] Telix, a commercia ...
announces the receipt of the Medicines & Healthcare products Regulatory Agency (MHRA) approvals for the FemaSeed® Intratubal Insemination product for female infertility treatment and two ...
Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...
Vietnam Investment Review on MSN4d
Illuccix Approved in the United Kingdom
Telix Pharmaceuticals Limited today announces that the United Kingdom Medicines and Healthcare Products Regulatory Agency has ...
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.